Petter Inge Anderssen

Tilsatt
ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Resultater Resultater

Discovery and development of safe-in-man broad-spectrum antiviral agents.

Anderssen, Petter Inge; Ianevski, Aleksandr; Lysvand, Hilde; Vitkauskiene, Astra; Oksenych, Valentyn; Bjørås, Magnar; Telling, Kaidi; Lutsar, Irja; Dumpis, Uga; Irie, Yasuhiko mfl.. 2020, International Journal of Infectious Diseases. FIMM, LATVIA, HY-HU, TÜ, NTNU, HYKS, LSMUVitenskapelig oversiktsartikkel/review

Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine.

Anderssen, Petter Inge; Krpina, Klara; Ianevski, Aleksandr; Shtaida, Nastassia; Jo, Eunji; Yang, Jaewon; Koit, Sandra; Tenson, Tanel; Hukkanen, Veijo; Anthonsen, Marit Walbye mfl.. 2019, Viruses. Ty, TÜ, NTNU, SØRKOREA, UMUVitenskapelig artikkel

Common nodes of virus-host interaction revealed through an integrated network analysis.

Bösl, Korbinian; Ianevski, Aleksandr; Than, Thoa T.; Anderssen, Petter Inge; Kuivanen, Suvi; Teppor, Mona; Zusinaite, Eva; Dumpis, Uga; Vitkauskiene, Astra; Cox, Rebecca Jane mfl.. 2019, Frontiers in Immunology. Uu, ETHZ, TÜ, NTNU, PSK, SØRKOREA, OUS, LSMU, MUW, UIB, ÖAW, HY-HU, UMASS, UIO, HYKSVitenskapelig artikkel

Expanding the activity spectrum of antiviral agents.

Ianevski, Aleksandr; Anderssen, Petter Inge; Merits, Andres; Bjørås, Magnar; Kainov, Denis. 2019, Drug Discovery Today. TÜ, NTNU, UIO, OUSVitenskapelig oversiktsartikkel/review

1 - 4 av 4